Thank you, Mr. Chair.
First, thank you, Mr. Bélanger.
I want to thank all the witnesses for their presentations.
My first question is for you three. As the roadmap is already coming to an end, we are anxiously awaiting the mid-term evaluation. We have not heard about your summative evaluations. Have you started them? Exactly where are you in that process?
Anyone can answer first. Go ahead, Mr. Watson.